Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019

ince the introduction of direct oral anticoagulants (DOACs), multiple large studies have demonstrated that DOACs are more effective, have fewer bleeding risks, and require less monitoring when compared with warfarin. 1Given the rising use of DOACs, the many anticoagulation indications that require lifelong therapy and the current lack of generic DOAC formulations, we examine contemporary DOAC spending patterns within Medicare Part D and Medicaid between 2014 and 2019.All three data sets used are publicly available and are readily accessible at https://www.cms.gov/Research-Stati stics -Data-and-Syste ms/Stati stics -Trend s-and-Repor ts/Infor matio n-on-Presc ripti on-Drugs/ Medic arePartD, https://www.cms.